Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 17:31:27 UTC
Update Date2021-09-26 23:12:53 UTC
HMDB IDHMDB0256899
Secondary Accession NumbersNone
Metabolite Identification
Common NamePsilocybine
DescriptionPsilocybin, also known as indocybin, belongs to the class of organic compounds known as tryptamines and derivatives. Tryptamines and derivatives are compounds containing the tryptamine backbone, which is structurally characterized by an indole ring substituted at the 3-position by an ethanamine. Psilocybin is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on Psilocybin. This compound has been identified in human blood as reported by (PMID: 31557052 ). Psilocybine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Psilocybine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
3-(2-(Dimethylamino)ethyl)-1H-indol-4-ol dihydrogen phosphate esterChEBI
3-(2-Dimethylaminoethyl)indol-4-yl dihydrogen phosphateChEBI
4-Phosphoryloxy-N,N-dimethyltryptamineChEBI
IndocybinChEBI
O-Phosphoryl-4-hydroxy-N,N-dimethyltryptamineChEBI
PsilocibinaChEBI
Psilocin phosphate esterChEBI
PsilocybineChEBI
PsilocybinumChEBI
3-(2-(Dimethylamino)ethyl)-1H-indol-4-ol dihydrogen phosphoric acid esterGenerator
3-(2-Dimethylaminoethyl)indol-4-yl dihydrogen phosphoric acidGenerator
Psilocin phosphoric acid esterGenerator
PsilocibinMeSH
Chemical FormulaC12H17N2O4P
Average Molecular Weight284.2481
Monoisotopic Molecular Weight284.092593554
IUPAC Name({3-[2-(dimethylamino)ethyl]-1H-indol-4-yl}oxy)phosphonic acid
Traditional Namepsilocybin
CAS Registry NumberNot Available
SMILES
CN(C)CCC1=CNC2=CC=CC(OP(O)(O)=O)=C12
InChI Identifier
InChI=1S/C12H17N2O4P/c1-14(2)7-6-9-8-13-10-4-3-5-11(12(9)10)18-19(15,16)17/h3-5,8,13H,6-7H2,1-2H3,(H2,15,16,17)
InChI KeyQVDSEJDULKLHCG-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as tryptamines and derivatives. Tryptamines and derivatives are compounds containing the tryptamine backbone, which is structurally characterized by an indole ring substituted at the 3-position by an ethanamine.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassIndoles and derivatives
Sub ClassTryptamines and derivatives
Direct ParentTryptamines and derivatives
Alternative Parents
Substituents
  • Tryptamine
  • Aryl phosphate
  • Aryl phosphomonoester
  • 3-alkylindole
  • Indole
  • Alkaloid or derivatives
  • Aralkylamine
  • Organic phosphoric acid derivative
  • Phosphoric acid ester
  • Substituted pyrrole
  • Benzenoid
  • Pyrrole
  • Heteroaromatic compound
  • Tertiary aliphatic amine
  • Tertiary amine
  • Azacycle
  • Amine
  • Organopnictogen compound
  • Organic oxygen compound
  • Organic nitrogen compound
  • Organooxygen compound
  • Organonitrogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP1.25ALOGPS
logP-0.14ChemAxon
logS-2ALOGPS
pKa (Strongest Acidic)1.74ChemAxon
pKa (Strongest Basic)9.54ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area85.79 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity73.3 m³·mol⁻¹ChemAxon
Polarizability27.82 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M-2H]-187.28430932474
DeepCCS[M+Na]+163.3230932474
AllCCS[M+H]+164.132859911
AllCCS[M+H-H2O]+160.632859911
AllCCS[M+NH4]+167.332859911
AllCCS[M+Na]+168.332859911
AllCCS[M-H]-163.732859911
AllCCS[M+Na-2H]-163.832859911
AllCCS[M+HCOO]-163.932859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.3.94 minutes32390414
Predicted by Siyang on May 30, 20229.2743 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20225.99 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid393.8 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid251.7 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid88.5 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid171.4 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid71.0 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid296.7 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid268.5 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)965.2 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid607.1 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid41.6 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid534.9 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid164.1 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid220.5 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate927.7 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA576.6 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water334.5 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
PsilocybineCN(C)CCC1=CNC2=CC=CC(OP(O)(O)=O)=C123346.1Standard polar33892256
PsilocybineCN(C)CCC1=CNC2=CC=CC(OP(O)(O)=O)=C122272.7Standard non polar33892256
PsilocybineCN(C)CCC1=CNC2=CC=CC(OP(O)(O)=O)=C122596.8Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Psilocybine,1TMS,isomer #1CN(C)CCC1=C[NH]C2=CC=CC(OP(=O)(O)O[Si](C)(C)C)=C122368.2Semi standard non polar33892256
Psilocybine,1TMS,isomer #1CN(C)CCC1=C[NH]C2=CC=CC(OP(=O)(O)O[Si](C)(C)C)=C122475.6Standard non polar33892256
Psilocybine,1TMS,isomer #1CN(C)CCC1=C[NH]C2=CC=CC(OP(=O)(O)O[Si](C)(C)C)=C123065.5Standard polar33892256
Psilocybine,1TMS,isomer #2CN(C)CCC1=CN([Si](C)(C)C)C2=CC=CC(OP(=O)(O)O)=C122412.2Semi standard non polar33892256
Psilocybine,1TMS,isomer #2CN(C)CCC1=CN([Si](C)(C)C)C2=CC=CC(OP(=O)(O)O)=C122459.2Standard non polar33892256
Psilocybine,1TMS,isomer #2CN(C)CCC1=CN([Si](C)(C)C)C2=CC=CC(OP(=O)(O)O)=C123181.5Standard polar33892256
Psilocybine,2TMS,isomer #1CN(C)CCC1=C[NH]C2=CC=CC(OP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)=C122409.3Semi standard non polar33892256
Psilocybine,2TMS,isomer #1CN(C)CCC1=C[NH]C2=CC=CC(OP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)=C122546.3Standard non polar33892256
Psilocybine,2TMS,isomer #1CN(C)CCC1=C[NH]C2=CC=CC(OP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)=C122759.2Standard polar33892256
Psilocybine,2TMS,isomer #2CN(C)CCC1=CN([Si](C)(C)C)C2=CC=CC(OP(=O)(O)O[Si](C)(C)C)=C122393.9Semi standard non polar33892256
Psilocybine,2TMS,isomer #2CN(C)CCC1=CN([Si](C)(C)C)C2=CC=CC(OP(=O)(O)O[Si](C)(C)C)=C122501.1Standard non polar33892256
Psilocybine,2TMS,isomer #2CN(C)CCC1=CN([Si](C)(C)C)C2=CC=CC(OP(=O)(O)O[Si](C)(C)C)=C122896.9Standard polar33892256
Psilocybine,3TMS,isomer #1CN(C)CCC1=CN([Si](C)(C)C)C2=CC=CC(OP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)=C122459.1Semi standard non polar33892256
Psilocybine,3TMS,isomer #1CN(C)CCC1=CN([Si](C)(C)C)C2=CC=CC(OP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)=C122551.6Standard non polar33892256
Psilocybine,3TMS,isomer #1CN(C)CCC1=CN([Si](C)(C)C)C2=CC=CC(OP(=O)(O[Si](C)(C)C)O[Si](C)(C)C)=C122693.4Standard polar33892256
Psilocybine,1TBDMS,isomer #1CN(C)CCC1=C[NH]C2=CC=CC(OP(=O)(O)O[Si](C)(C)C(C)(C)C)=C122590.2Semi standard non polar33892256
Psilocybine,1TBDMS,isomer #1CN(C)CCC1=C[NH]C2=CC=CC(OP(=O)(O)O[Si](C)(C)C(C)(C)C)=C122679.8Standard non polar33892256
Psilocybine,1TBDMS,isomer #1CN(C)CCC1=C[NH]C2=CC=CC(OP(=O)(O)O[Si](C)(C)C(C)(C)C)=C123204.1Standard polar33892256
Psilocybine,1TBDMS,isomer #2CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC(OP(=O)(O)O)=C122643.5Semi standard non polar33892256
Psilocybine,1TBDMS,isomer #2CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC(OP(=O)(O)O)=C122633.4Standard non polar33892256
Psilocybine,1TBDMS,isomer #2CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC(OP(=O)(O)O)=C123229.0Standard polar33892256
Psilocybine,2TBDMS,isomer #1CN(C)CCC1=C[NH]C2=CC=CC(OP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C122810.2Semi standard non polar33892256
Psilocybine,2TBDMS,isomer #1CN(C)CCC1=C[NH]C2=CC=CC(OP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C122934.5Standard non polar33892256
Psilocybine,2TBDMS,isomer #1CN(C)CCC1=C[NH]C2=CC=CC(OP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C123014.2Standard polar33892256
Psilocybine,2TBDMS,isomer #2CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC(OP(=O)(O)O[Si](C)(C)C(C)(C)C)=C122811.6Semi standard non polar33892256
Psilocybine,2TBDMS,isomer #2CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC(OP(=O)(O)O[Si](C)(C)C(C)(C)C)=C122869.3Standard non polar33892256
Psilocybine,2TBDMS,isomer #2CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC(OP(=O)(O)O[Si](C)(C)C(C)(C)C)=C123083.7Standard polar33892256
Psilocybine,3TBDMS,isomer #1CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC(OP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C123022.7Semi standard non polar33892256
Psilocybine,3TBDMS,isomer #1CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC(OP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C123045.9Standard non polar33892256
Psilocybine,3TBDMS,isomer #1CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=CC(OP(=O)(O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C122984.0Standard polar33892256
Spectra
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB11664
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDC00051822
Chemspider ID10178
KEGG Compound IDC07576
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkPsilocybin
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI ID8614
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]